Search
for
Sort by
Research 31–60 of 1000+
- Anthracycline analogs The past, present, and future
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- Impact of Chemotherapeutic Drug on People living with Cancer
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- The PDGF/PDGFR pathway as a drug target
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- INTERFERONS IN DERMATOLOGY
- An Update on Drug-Induced Pigmentation
- Epigenetic regulation in adult stem cells and cancers
- KY19382, a novel activator of Wnt/β‐catenin signalling, promotes hair regrowth and hair follicle neogenesis
- Clinical Development of Topoisomerase-Interactive Drugs
- Conceptual Basis for Use of Chemotherapeutic Agents and Their Pharmacology
- Cutaneous drug reactions
- Dermatological drugs, topical agents, and cosmetics
- Comparative analysis of stemness between dermal papilla cells and human dermalstem/progenitor cells
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Mucocutaneous reactions to chemotherapy
- Cutaneous complications of chemotherapeutic agents
- Cutaneous reactions to recombinant cytokine therapy
- Hair disorders in patients with cancer
- ADVANCES IN PSORIASIS THERAPY
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Thrombocytosis Associated with Low-Molecular-Weight Heparin
- Adult Group B Streptococcal Disease
- Alopecia Associated with Fluconazole Therapy
- Role of Dermal Melanocytes in Cutaneous Pigmentation of Stasis Dermatitis